These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 24441026)
21. In vivo genotoxicity of dichloroacetic acid: evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay. Fuscoe JC; Afshari AJ; George MH; DeAngelo AB; Tice RR; Salman T; Allen JW Environ Mol Mutagen; 1996; 27(1):1-9. PubMed ID: 8625942 [TBL] [Abstract][Full Text] [Related]
22. Micronucleus and comet assay in the peripheral blood of juvenile rat: establishment of assay feasibility, time of sampling and the induction of DNA damage. Mughal A; Vikram A; Ramarao P; Jena GB Mutat Res; 2010 Jul; 700(1-2):86-94. PubMed ID: 20561993 [TBL] [Abstract][Full Text] [Related]
23. First in vivo evaluation of the mutagenic effect of Brazilian green propolis by comet assay and micronucleus test. Pereira AD; de Andrade SF; de Oliveira Swerts MS; Maistro EL Food Chem Toxicol; 2008 Jul; 46(7):2580-4. PubMed ID: 18468757 [TBL] [Abstract][Full Text] [Related]
24. Increased MMAB level in mitochondria as a novel biomarker of hepatotoxicity induced by Efavirenz. Tan Z; Jia X; Ma F; Feng Y; Lu H; Jin JO; Wu D; Yin L; Liu L; Zhang L PLoS One; 2017; 12(11):e0188366. PubMed ID: 29190729 [TBL] [Abstract][Full Text] [Related]
26. Screening of codeine, dextromethorphan & dextropropoxyphene for their genotoxicity in Swiss albino mice. Mittal R; Patil PA; Torgal SS Indian J Med Res; 2009 Jun; 129(6):676-80. PubMed ID: 19692748 [TBL] [Abstract][Full Text] [Related]
27. Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenz. van Leth F; Conway B; Laplumé H; Martin D; Fisher M; Jelaska A; Wit FW; Lange JM; Antivir Ther; 2004 Oct; 9(5):721-8. PubMed ID: 15535409 [TBL] [Abstract][Full Text] [Related]
28. Genotoxicity of sodium metabisulfite in mouse tissues evaluated by the comet assay and the micronucleus test. Carvalho IM; Melo Cavalcante AA; Dantas AF; Pereira DL; Costa Rocha FC; Andrade TJ; Da Silva J Mutat Res; 2011 Feb; 720(1-2):58-61. PubMed ID: 21185391 [TBL] [Abstract][Full Text] [Related]
29. In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results. Gianotti N; Boeri E; Maillard M; Serra G; Ratti D; Gallotta G; Vacchini D; Tremolada Y; Castagna A New Microbiol; 2004 Apr; 27(2 Suppl 1):111-7. PubMed ID: 15646073 [TBL] [Abstract][Full Text] [Related]
30. Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother-child pairs to AZT or AZT-3TC. Escobar PA; Olivero OA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Day RD; Day BW; Meng Q; O'Neill JP; Walker DM; Poirier MC; Walker VE; Bigbee WL Environ Mol Mutagen; 2007; 48(3-4):330-43. PubMed ID: 17358027 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of multi-organ DNA damage by comet assay from 28 days repeated dose oral toxicity test in mice: a practical approach for test integration in regulatory toxicity testing. Kushwaha S; Tripathi DN; Vikram A; Ramarao P; Jena GB Regul Toxicol Pharmacol; 2010 Oct; 58(1):145-54. PubMed ID: 20488216 [TBL] [Abstract][Full Text] [Related]
32. Genotoxicity assessment of the antimalarial compound artesunate in somatic cells of mice. Aquino I; Perazzo FF; Maistro EL Food Chem Toxicol; 2011 Jun; 49(6):1335-9. PubMed ID: 21419820 [TBL] [Abstract][Full Text] [Related]
33. The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*. Cozzi-Lepri A; Paredes ; Phillips AN; Clotet B; Kjaer J; Von Wyl V; Kronborg G; Castagna A; Bogner JR; Lundgren JD; HIV Med; 2012 Jan; 13(1):62-72. PubMed ID: 21848790 [TBL] [Abstract][Full Text] [Related]
34. Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies. Shi J; Krsmanovic L; Bruce S; Kelly T; Paranjpe M; Szabo K; Arevalo M; Atta-Safoh S; Debelie F; LaForce MK; Sly J; Springer S Environ Mol Mutagen; 2011 Dec; 52(9):711-20. PubMed ID: 21976072 [TBL] [Abstract][Full Text] [Related]
35. Genotoxicity evaluation of dimethoate to experimental mice by micronucleus, chromosome aberration tests, and comet assay. Ayed-Boussema I; Rjiba K; Mnasri N; Moussa A; Bacha H Int J Toxicol; 2012; 31(1):78-85. PubMed ID: 21994239 [TBL] [Abstract][Full Text] [Related]
36. Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana. Tolle M; Howard L; Kirk B; Gomila A; Schwarzwald H; Anabwani G J Int Assoc Physicians AIDS Care (Chic); 2012; 11(4):260-8. PubMed ID: 21972264 [TBL] [Abstract][Full Text] [Related]
37. Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir. Abgrall S; Yeni PG; Bouchaud O; Costagliola D; AIDS; 2006 Oct; 20(16):2099-106. PubMed ID: 17053356 [TBL] [Abstract][Full Text] [Related]